verified SJR 0,936 · Q1 • database Scopus / SJR & Web of Science indexed

International Journal of Clinical Oncology

Japan · Springer Japan

workspace_premium Q1 — Medicine (miscellaneous) lock_open Open Access

International Journal of Clinical Oncology

The International Journal of Clinical Oncology (IJCO) welcomes original and review papers on all aspects of clinical oncology that report the results of novel and timely investigations. Reports on clinical trials are encouraged. Priority is given to high-quality clinical articles...

ISSN: 1341-9625

Publisher: Springer Japan

Category: Medicine (miscellaneous)

Indexation: verifiedScopus / SJR verifiedWeb of Science

open_in_new Visit publisher site menu_book Guidelines NPD

schedule CountryOfPapers database fields

SJR Impact Factor trending_up

0,936 Q1

H-index 78

Acceptance rate pie_chart

28% Selective

Source Acceptance_Rate

Time to publication hourglass_top

NPD

Field NPD

Publication cost (APC) payments

3.190 € Open Access

Non-OA path 0 €

Metrics

Scimago and CountryOfPapers database fields

Scopus / SJR Web of Science

SJR Impact

0,936

H-index

Docs (year)

216

Docs 3y

615

Total refs

7103

Cites 3y

1659

Citable 3y

611

Cites/Doc 2y

2.78

Ref/Doc

32.88

Immediate OA

3190 €

Embargoed OA

NPD

Non OA / Submission

0 €

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims

rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID * * Only to validate authenticity — identity is not shown publicly.

Best articles by citations

Bacillus Calmette?Guerin-refractory superficial bladder cancers: focus on pretreatment episodes

Weekly docetaxel for patients with platinum/paclitaxel/irinotecan-resistant relapsed ovarian cancer: a phase I study

Combination chemotherapy with paclitaxel and intraperitoneal cisplatin for ovarian cancer with disseminated lesions in the peritoneum and the diaphragm

Combination chemotherapy of low-dose 5-fluorouracil and cisplatin for advanced extramammary Paget's disease

Clinical trial of fundoscopy under general anesthesia for pediatric outpatients with retinoblastoma

Clinical outcomes of patients with epithelioid sarcomas: impact and management of nodal metastasis

Clinical outcome of transrectal ultrasound-guided prostate biopsy, targeting eight cores, for detecting prostate cancer in Japanese men

Clinical implications of dihydropyrimidine dehydrogenase (DPD) activity in 5-FU-based chemotherapy: mutations in the DPD gene, and DPD inhibitory fluoropyrimidines

Clinical and pathological study of gastric cancer with ovarian metastasis

Carbon-ion radiotherapy for lymph node oligo-recurrence: a multi-institutional study by the Japan Carbon-Ion Radiation Oncology Study Group (J-CROS)

Cancer, genes, and catechol estrogen metabolites

C(H)OP refractory chronic lymphocytic leukemia patients in whom salvage chemotherapy chosen by evaluating multiple chemotherapeutic drug-resistant factors was remarkably effective

SHOW MORE ARTICLES

Biweekly paclitaxel in patients with metastatic breast cancer

5-Fluorouracil and dihydropyrimidine dehydrogenase

Assessing a new surgical procedure: an initial step to randomized trial

Application of tyramide signal amplification for detection of N-glycolylneuraminic acid in human hepatocellular carcinoma

Antitumor and antivascular effects of AC-7700, a combretastatin A-4 derivative, against rat liver cancer

Antibodies as molecular target-based therapy: trastuzumab

Anaphylaxis to cisplatin following nine previous uncomplicated cycles

Activity and safety of a low dose, fractional administration of irinotecan hydrochloride (CPT-11) in combination with cisplatin for relapsed gastric cancer patients: a preliminary report

Active chemotherapy for bone metastasis in sarcomatoid renal cell carcinoma

A successful case of oral molecularly targeted therapy with imatinib for peritoneal metastasis of a gastrointestinal stromal tumor

A pilot study of neoadjuvant chemotherapy with mitomycin C, etoposide, cisplatin, and epirubicin for adenocarcinoma of the cervix

A new risk stratification model for intravesical recurrence, disease progression, and cancer-specific death in patients with non-muscle invasive bladder cancer: the J-NICE risk tables

FAQs

International Journal of Clinical Oncology has an SJR of 0,936 (best quartile Q1) in the CountryOfPapers database.

Immediate OA APC is 3190 EUR. Non-OA / submission fee is 0 EUR.

The acceptance rate recorded for International Journal of Clinical Oncology is 28%.

International Journal of Clinical Oncology

Metrics

Name good journals. Call out predatory ones.

Researcher reviews

Best articles by citations

FAQs

What is the SJR of International Journal of Clinical Oncology?

What is the APC / publication cost?

What is the acceptance rate?